Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2013 12:10 ET | Source: Spherix Incorporated

Spherix Announces New Interim Chief Executive Officer

TYSONS CORNER, Va., Feb. 28, 2013 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – today announced the naming of an interim Chief Executive Officer. Harvey Kesner, currently a director,...
December 03, 2012 08:36 ET | Source: Spherix Incorporated

Spherix Announces Restructuring

BETHESDA, Md., Dec. 3, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – today announced that, as an initial step in its restructuring program, it has sold all of the stock of...
November 15, 2012 14:45 ET | Source: Spherix Incorporated

Spherix Announces Third Quarter 2012 Financial Results

BETHESDA, Md., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...
November 15, 2012 09:56 ET | Source: Spherix Incorporated

Spherix and Fullife Healthcare Sign Supply and License Agreement for D-Tagatose in Nutraceutical Products in India

BETHESDA, Md. and MUMBAI, India, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and...
November 12, 2012 12:29 ET | Source: Spherix Incorporated

Spherix Announces Closing of Private Placement of $2.6 Million in Common Stock and Warrants

BETHESDA, Md., Nov. 12, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...
November 08, 2012 14:51 ET | Source: Spherix Incorporated

Spherix to Raise $2.6 Million in Private Placement

BETHESDA, M.D., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...
September 21, 2012 10:07 ET | Source: Spherix Incorporated

Spherix Announces Reverse Stock Split Effective September 21, 2012

BETHESDA, Md., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq: SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and...
September 06, 2012 12:15 ET | Source: Spherix Incorporated

Spherix to Effect Reverse Stock Split

BETHESDA, Md., Sept. 6, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...
September 04, 2012 09:20 ET | Source: Spherix Incorporated

Spherix Incorporated to Present at the Rodman & Renshaw 14th Annual Healthcare Conference

BETHESDA, Md., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nasdaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...
August 13, 2012 14:16 ET | Source: Spherix Incorporated

Photo Release -- Preclinical Study With SPX106T Reduces Growth Rate of Abdominal Aortic Aneurysms

BETHESDA, Md., Aug. 13, 2012 (GLOBE NEWSWIRE) -- Spherix Incorporated (Nadsaq:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider...